Grove Technical Resources, INC reposted this
BREAKING: The European Commission has approved our one-time gene therapy for adults with #hemophilia B, providing an option for eligible patients who have typically required regular intravenous infusions. Read more: https://lnkd.in/gQxhjzii
Science always wins 👍
Great achievement for Pfizer. We will continue our journey to pursuit breakthroughs that change patients’ lives.
What is the rationale for patients without detectable antibodies to variants rh74?
Awesome to hear!
Great achievement for Pfizer!
amazing news!
Congratulations to Spark for the discovery and devlopment of fidanacogene elaparvovec, and to Pfizer for completing the Phase III trials and getting it approved! Huge accomplishment by both organizations, and huge impact on the HemB patient community. Well done to all involved!
Hope you survive the layoffs
Congratulations to Pfizer on the European Commission's approval of your one-time gene therapy for hemophilia B! 🌟 This is a significant advancement for patients who have relied on frequent infusions. Excited to see how this innovative therapy will impact lives. #HemophiliaB #GeneTherapy #Innovation #Healthcare
Associate Director Standards at Pfizer(Senior Statistical Data Science Lead)
3moMy team got a great opportunity to work on this study!!